DK0511991T3 - Farmaceutisk formulering - Google Patents

Farmaceutisk formulering

Info

Publication number
DK0511991T3
DK0511991T3 DK91902429.9T DK91902429T DK0511991T3 DK 0511991 T3 DK0511991 T3 DK 0511991T3 DK 91902429 T DK91902429 T DK 91902429T DK 0511991 T3 DK0511991 T3 DK 0511991T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
DK91902429.9T
Other languages
Danish (da)
English (en)
Inventor
Hazel-Ann Griffiths
Alan John Goodall
Joshua Oduro-Yeboah
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of DK0511991T3 publication Critical patent/DK0511991T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91902429.9T 1990-01-26 1991-01-24 Farmaceutisk formulering DK0511991T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909001886A GB9001886D0 (en) 1990-01-26 1990-01-26 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
DK0511991T3 true DK0511991T3 (da) 1996-11-11

Family

ID=10669997

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91902429.9T DK0511991T3 (da) 1990-01-26 1991-01-24 Farmaceutisk formulering

Country Status (29)

Country Link
EP (1) EP0511991B1 (ko)
JP (1) JP2545317B2 (ko)
KR (1) KR0170414B1 (ko)
CN (1) CN1056058C (ko)
AP (1) AP197A (ko)
AT (1) ATE142880T1 (ko)
AU (1) AU643975B2 (ko)
CA (1) CA2074503C (ko)
CY (2) CY1984A (ko)
DE (1) DE69122229T2 (ko)
DK (1) DK0511991T3 (ko)
ES (1) ES2092559T3 (ko)
FI (1) FI101600B1 (ko)
GB (1) GB9001886D0 (ko)
GR (1) GR3021385T3 (ko)
HK (1) HK218996A (ko)
HU (1) HU215842B (ko)
IE (1) IE910249A1 (ko)
IL (1) IL97008A (ko)
LU (1) LU90110I2 (ko)
MA (1) MA22051A1 (ko)
MY (1) MY110074A (ko)
PL (1) PL166678B1 (ko)
PT (1) PT96563B (ko)
SA (1) SA91110341B1 (ko)
SG (1) SG49144A1 (ko)
TW (1) TW307687B (ko)
WO (1) WO1991011187A1 (ko)
ZA (1) ZA91525B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition
WO2019195802A1 (en) * 2018-04-05 2019-10-10 Bausch Health Ireland Limited Polymeric emulsion delivery systems

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
EP0152316B1 (en) * 1984-01-26 1989-07-26 Merck & Co. Inc. Substituted butyl guanines and their utilization in antiviral compositions
EP0216459B1 (en) * 1985-07-27 1990-05-16 Beecham Group Plc 9-substituted guanine monohydrates

Also Published As

Publication number Publication date
IE910249A1 (en) 1991-07-31
LU90110I2 (fr) 1997-09-25
AU7155891A (en) 1991-08-21
ATE142880T1 (de) 1996-10-15
MY110074A (en) 1997-12-31
CA2074503A1 (en) 1991-07-27
HU215842B (hu) 2001-02-28
HU9202431D0 (en) 1992-10-28
CY1999020I2 (en) 2009-11-04
GB9001886D0 (en) 1990-03-28
WO1991011187A1 (en) 1991-08-08
ZA91525B (en) 1992-02-26
HK218996A (en) 1997-01-03
FI101600B (fi) 1998-07-31
SA91110341B1 (ar) 2004-05-25
AP9000236A0 (en) 1991-01-31
EP0511991A1 (en) 1992-11-11
CN1053547A (zh) 1991-08-07
IL97008A (en) 1995-05-26
PL166678B1 (pl) 1995-06-30
DE69122229T2 (de) 1997-03-06
FI923371A (fi) 1992-07-24
MA22051A1 (fr) 1991-10-01
EP0511991B1 (en) 1996-09-18
ES2092559T3 (es) 1996-12-01
CN1056058C (zh) 2000-09-06
TW307687B (ko) 1997-06-11
SG49144A1 (en) 1998-05-18
HUT62472A (en) 1993-05-28
FI101600B1 (fi) 1998-07-31
JPH05503695A (ja) 1993-06-17
DE69122229D1 (de) 1996-10-24
PT96563B (pt) 1998-07-31
GR3021385T3 (en) 1997-01-31
PT96563A (pt) 1991-10-15
AU643975B2 (en) 1993-12-02
CY1984A (en) 1997-09-05
FI923371A0 (fi) 1992-07-24
JP2545317B2 (ja) 1996-10-16
KR0170414B1 (ko) 1999-02-18
KR920703060A (ko) 1992-12-17
AP197A (en) 1992-06-30
CA2074503C (en) 1999-12-14
IL97008A0 (en) 1992-03-29

Similar Documents

Publication Publication Date Title
FI934914A (fi) Farmaceutiska formuleringar
DK0515312T3 (da) Farmaceutisk præparat
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
FI922252A (fi) Farmaceutisk sammansaettning
DK481989D0 (da) Farmaceutiske formuleringer
DK0394026T3 (da) Formulering
FI923581A (fi) Farmaceutisk kombinationsformation
FI930882A0 (fi) Farmaceutiska foereningar
FI925778A (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
MX9200622A (es) Composicion farmaceutica
FI931251A0 (fi) Farmaceutiska foereningar
UA26064A1 (uk) Фармацевтичhа композиція
MX9204183A (es) Formulacion de prostagladina e1
DK0511991T3 (da) Farmaceutisk formulering
DK137591A (da) Fast farmaceutisk praeparat
NO306381B1 (no) Farmasöytisk ampulle
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
DK207590D0 (da) Farmaceutisk praeparat
DK204190D0 (da) Farmaceutisk praeparat
KR920010907U (ko) 약제 살포기
SE9103213D0 (sv) Farmaceutisk komposition
SE9101348D0 (sv) Pharmaceutical composition
FI971316A (fi) Farmaseuttinen yhdiste
NO920564L (no) Farmasoeytiske adenosinholdige preparater